ArticleCancer research2018
Silencing of Long Noncoding RNA
Open access · greenAbstract read
In one paragraph
Article in Cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.
0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
97 citing papers in PubMed, 141 citations in OpenAlex.
- LncRNA MIR22HG and miR-10a-5p: Pioneering serum biomarkers for pancreatic cancer diagnosis and progression assessment.Non-coding RNA research · 2026Article
- Identification and functional validation of EPS15L1 as a key driver of triple-negative breast cancer.NPJ breast cancer · 2026Article
- SIN3A promotes lung adenocarcinoma by repressing MIR22HG/Beclin1 axis-mediated autophagy and ferroptosis.European journal of medical research · 2026Article
- Long Non-coding RNA MIR22HG Alleviates Ischemic Acute Kidney Injury by Targeting the miR-134-5p/NFAT5 axis.Inflammation · 2025Article
- Article
- An integrated analysis of scRNA-seq and RNA-seq data revealed metastasis-related regulators as prognostic indicators in lung adenocarcinoma.Journal of thoracic disease · 2025Article
- MicroRNA Gets a Mighty Award.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
- The Role of microRNA-22 in Metabolism.International journal of molecular sciences · 2025Review
- Review of the Different Outcomes Produced by Genetic Knock Out of the Long Non-coding microRNA-host-gene MIR22HGMicroRNA (Shariqah, United Arab Emirates) · 2025Review
- YBX1: an RNA/DNA-binding protein that affects disease progression.Frontiers in oncology · 2025Review
- Senescence-associated secretory phenotype in lung cancer: remodeling the tumor microenvironment for metastasis and immune suppression.Frontiers in oncology · 2025Review
- Review
- MIR194-2HG, a miRNA host gene activated by HNF4A, inhibits gastric cancer by regulating microRNA biogenesis.Biology direct · 2024Article
- LncRNAs are involved in regulating ageing and age-related disease through the adenosine monophosphate-activated protein kinase signalling pathway.Genes & diseases · 2024Review
- Mir22hg facilitates ferritinophagy-mediated ferroptosis in sepsis by recruiting the m6A reader YTHDC1 and enhancing Angptl4 mRNA stability.Journal of bioenergetics and biomembranes · 2024Article
- TargetingActa biochimica et biophysica Sinica · 2024Article
- Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation.Journal of experimental & clinical cancer research : CR · 2024Review
- Suppression of the long non-coding RNA LINC01279 triggers autophagy and apoptosis in lung cancer by regulating FAK and SIN3A.Discover oncology · 2024Article
- Silencing of the long non-coding RNAOncology research · 2024Article
- PFKP silencing suppresses tumor growth via the AXL-MET axis.International journal of biological sciences · 2024Article
37 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
15 authors at 1 institution in 1 country.
Wenmei SuDepartment of Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Shumei FengXinjiang Medical University, Urumqi, China.
Xiuyuan ChenPeking University People's Hospital, Beijing, China.
Xia YangXian Jiaotong University, Xi'an, China.
Rui MaoXinjiang Medical University, Urumqi, China.
Chunfang GuoSection of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan.
Zhuwen WangSection of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan.
Dafydd G ThomasDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.
Jules LinSection of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan.
Rishindra M ReddySection of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan.
Mark B OrringerSection of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan.
Andrew C ChangSection of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan.
Zhixiong YangDepartment of Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. guoanche@umich.edu yangzhixiong1963@hotmail.com.
David G BeerSection of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan.
Guoan ChenSection of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan. guoanche@umich.edu yangzhixiong1963@hotmail.com.
Peking University · CN
Funding
XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2MSquamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for PrognU01CA157715 · NCI · UNIVERSITY OF COLORADO DENVER · PI HIRSCH, FRED R · 2012 to 2016
$2.9MIdentification and Characterization of Gene Fusions in Lung AdenocarcinomaR01CA154365 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BEER, DAVID GEORGE, CHINNAIYAN, ARUL M · 2011 to 2015
$1.4MValidation of 4-miRNA signature for early lung cancer detectionR21CA205414 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHEN, GUOAN · 2016 to 2017
$382kNCI NIH HHS P30 CA046592NCI NIH HHS R01 CA154365NCI NIH HHS R21 CA205414NCI NIH HHS U01 CA157715
Abstract
The long noncoding RNA (lncRNA)
Indexed as
Adenocarcinoma of LungAgedApoptosisCell Line, TumorCell SurvivalCyclin-Dependent Kinase Inhibitor p21Datasets as TopicDown-RegulationFemaleFollow-Up StudiesGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansLungLung NeoplasmsMaleCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21MET protein, humanMicroRNAsMIRN22 microRNA, humanProto-Oncogene Proteins c-metY-Box-Binding Protein 1YBX1 protein, human
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.